Intelligent Bio Solutions Inc. (INBS) — Financial statements
Income statement, balance sheet, and cash flow for Intelligent Bio Solutions Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3↓1.9% | 3↑147.6% | 1 | 0.00↓100.0% | 2 | |
| Cost of Revenue | 2↑7.1% | 2↑81.3% | 0.93 | 0.00 | 0.00 | |
| Gross Profit | 1↓12.5% | 1↑336.4% | 0.33 | 0.00↓100.0% | 2 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↑43.2% | 2↑229.9% | 0.51↓86.8% | 4↑0.5% | 4 | |
| General & Administrative Expenses | 7↓14.1% | 9 | 0.00↓100.0% | 5↑46.5% | 3 | |
| Selling & Marketing Expenses | 2↑114.3% | 0.73 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9↓4.0% | 9↑15.3% | 8↑63.1% | 5↑46.5% | 3 | |
| Other Expenses | 0.61↓21.3% | 0.78↓82.3% | 4↑1103.7% | -0.44↓221.7% | 0.36 | |
| Operating Expenses | 12↑1.6% | 12↓9.4% | 13↑55.0% | 8↑10.4% | 8 | |
| Total Costs & Expenses | 14↑2.3% | 13↓3.3% | 14↑66.2% | 8↑10.4% | 8 | |
| Operating Results | ||||||
| Operating Income | -11↓3.5% | -10↑18.4% | -13↓51.1% | -8↓49.6% | -6 | |
| Depreciation & Amortization | 0.97↓0.4% | 0.97↑0.8% | 0.97 | 0.00↓100.0% | 5 | |
| EBITDA | -9↓1.6% | -9↑1.7% | -9↓13.8% | -8 | 0.00 | |
| EBIT | -10↓1.4% | -10↑1.5% | -10↓25.4% | -8↓59.7% | -5 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.04↑149.4% | -0.08↑61.5% | -0.21↓3207.3% | 0.01↑100.6% | -1 | |
| Interest Income | 0.10↑19.7% | 0.08↑776.6% | 0.01↓32.9% | 0.01↑4.5% | 0.01 | |
| Interest Expense | 0.06↓63.6% | 0.17↓25.2% | 0.22↑2865.0% | 0.01↓99.3% | 1 | |
| Non-Operating Income | -0.22 | 0.00↑100.0% | -2↓20536.2% | -0.01↑97.1% | -0.36 | |
| Other Income / Expenses | 0.04↓56.9% | 0.09↓95.2% | 2↑66475.1% | 0.00↑100.2% | -1 | |
| Income Before Tax | -11↓4.1% | -10↑4.4% | -11↓28.0% | -8↓18.0% | -7 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -11↓4.1% | -10↑4.4% | -11↓28.0% | -8↓18.0% | -7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -11↓4.1% | -10↑4.5% | -11↓28.0% | -8↓18.0% | -7 | |
| Bottom-Line Net Income | -11↓4.1% | -10↑4.5% | -11↓28.0% | -8↓18.0% | -7 | |
| EPS (Basic) | -20.00↑68.7% | -63.80↑39.7% | -105.80↑6.6% | -113.30↑30.1% | -162.20 | |
| EPS (Diluted) | -20.00↑68.7% | -63.80↑39.7% | -105.80↑6.6% | -113.30↑30.1% | -162.20 | |
| Weighted Average Shares | 0.53↑65.6% | 0.32↑58.5% | 0.20↑174.0% | 0.07↑40.8% | 0.05 | |
| Weighted Average Diluted Shares | 0.53↑65.6% | 0.32↑58.5% | 0.20↑174.0% | 0.07↑40.8% | 0.05 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.